371 related articles for article (PubMed ID: 17549287)
1. Vasa vasorum and atherosclerosis - Quid novi?
Langheinrich AC; Kampschulte M; Buch T; Bohle RM
Thromb Haemost; 2007 Jun; 97(6):873-9. PubMed ID: 17549287
[TBL] [Abstract][Full Text] [Related]
2. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.
Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory angiogenesis in atherogenesis--a double-edged sword.
Ribatti D; Levi-Schaffer F; Kovanen PT
Ann Med; 2008; 40(8):606-21. PubMed ID: 18608127
[TBL] [Abstract][Full Text] [Related]
4. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
[TBL] [Abstract][Full Text] [Related]
5. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
[TBL] [Abstract][Full Text] [Related]
6. Vasa vasorum in atherosclerosis and clinical significance.
Xu J; Lu X; Shi GP
Int J Mol Sci; 2015 May; 16(5):11574-608. PubMed ID: 26006236
[TBL] [Abstract][Full Text] [Related]
7. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
Front Immunol; 2018; 9():706. PubMed ID: 29719532
[TBL] [Abstract][Full Text] [Related]
8. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
Boyle EC; Sedding DG; Haverich A
Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
[TBL] [Abstract][Full Text] [Related]
9. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis.
Gössl M; Versari D; Hildebrandt HA; Bajanowski T; Sangiorgi G; Erbel R; Ritman EL; Lerman LO; Lerman A
JACC Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 20129528
[TBL] [Abstract][Full Text] [Related]
10. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization.
Nakano M; Fukumoto Y; Satoh K; Ito Y; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
Cardiovasc Res; 2010 Dec; 88(3):539-46. PubMed ID: 20584752
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in atherosclerosis: gathering evidence beyond speculation.
Moulton KS
Curr Opin Lipidol; 2006 Oct; 17(5):548-55. PubMed ID: 16960504
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
Leroyer AS; Rautou PE; Silvestre JS; Castier Y; Lesèche G; Devue C; Duriez M; Brandes RP; Lutgens E; Tedgui A; Boulanger CM
J Am Coll Cardiol; 2008 Oct; 52(16):1302-11. PubMed ID: 18929241
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.
Virmani R; Kolodgie FD; Burke AP; Finn AV; Gold HK; Tulenko TN; Wrenn SP; Narula J
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2054-61. PubMed ID: 16037567
[TBL] [Abstract][Full Text] [Related]
14. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
Kolodgie FD; Narula J; Yuan C; Burke AP; Finn AV; Virmani R
J Am Coll Cardiol; 2007 May; 49(21):2093-101. PubMed ID: 17531658
[TBL] [Abstract][Full Text] [Related]
15. The vasa vasorum in diseased and nondiseased arteries.
Mulligan-Kehoe MJ
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H295-305. PubMed ID: 19940078
[TBL] [Abstract][Full Text] [Related]
16. Vasa Vasorum Restructuring in Human Atherosclerotic Plaque Vulnerability: A Clinical Optical Coherence Tomography Study.
Taruya A; Tanaka A; Nishiguchi T; Matsuo Y; Ozaki Y; Kashiwagi M; Shiono Y; Orii M; Yamano T; Ino Y; Hirata K; Kubo T; Akasaka T
J Am Coll Cardiol; 2015 Jun; 65(23):2469-77. PubMed ID: 26065984
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE
Wang F; Chen FF; Shang YY; Li Y; Wang ZH; Han L; Li YH; Zhang L; Ti Y; Zhang W; Zhong M
Int J Cardiol; 2018 Aug; 265():181-187. PubMed ID: 29685689
[TBL] [Abstract][Full Text] [Related]
18. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
[TBL] [Abstract][Full Text] [Related]
19. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development.
Gössl M; Versari D; Mannheim D; Ritman EL; Lerman LO; Lerman A
Atherosclerosis; 2007 Jun; 192(2):246-52. PubMed ID: 16919638
[TBL] [Abstract][Full Text] [Related]
20. Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice.
Tanaka K; Nagata D; Hirata Y; Tabata Y; Nagai R; Sata M
Atherosclerosis; 2011 Apr; 215(2):366-73. PubMed ID: 21306712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
